JB CHEMICALS & PHARMACEUTICALS
|
|
BOM : 506943     NSE : JBCHEPHARM     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward Pledged Shares : None or < 25% |
Jun 12,2025 |
Price(EOD): ₹ 1,745.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 27,241.01 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
JB CHEMICALS & PHARMACEUTICALS | 2.5% | 8.4% | -4.6% |
SUN PHARMACEUTICAL INDUSTRIES | 0.4% | -1.2% | 12.2% |
DIVIS LABORATORIES | 2.6% | 8.4% | 48.5% |
CIPLA | -0.1% | 0.5% | 1.7% |
TORRENT PHARMACEUTICALS | 3.4% | 0.5% | 12.8% |
DR REDDYS LABORATORIES | 3.2% | 11.8% | 11.4% |
MANKIND PHARMA | 1.4% | -6.4% | 11.8% |
ZYDUS LIFESCIENCES | 1.9% | 8.3% | -7.3% |
LUPIN | 1.2% | -2.4% | 24.5% |
FUNDAMENTAL ANALYSIS OF JB CHEMICALS & PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF JB CHEMICALS & PHARMACEUTICALS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
41.31
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 659.58 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] 7.94
P/B Calculated based on Book Value of Rs 3,433.32 Cr
[Latest Year - Mar2025 - Consolidated Results ] 6.95
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 3,917.99 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
183% 195% 186% |
SHARE PRICE MOMENTUM OF JB CHEMICALS & PHARMACEUTICALS
JB CHEMICALS & PHARMACEUTICALS vs SENSEX
DEBT OF JB CHEMICALS & PHARMACEUTICALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.12 0.23 0.01 0.12 |
0.13 0.23 0.01 0.12 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF JB CHEMICALS & PHARMACEUTICALS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2025 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF JB CHEMICALS & PHARMACEUTICALS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-1.45% -11.03% -11.45% -10.34% |
10.18% 14.29% 17.27% 15.48% |
QtrlyTrend |
0 | |
Latest Qtr: Mar2025 | ||
Quarterly Result Analysis → |
JB CHEMICALS & PHARMACEUTICALS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
BSE HEALTHCARE | 2.1% | 4.7% | 23.1% |
BSE 250 SMALLCAP INDEX | 0.9% | 8.7% | 8.5% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY PHARMA | 1.8% | 3.2% | 14.6% |
NIFTY SMALLCAP 250 | 0.6% | 9.2% | 9.7% |
NIFTY TOTAL MARKET | 0.5% | 3.3% | 8.1% |
NIFTY 500 | 0.5% | 3.1% | 7.9% |
NIFTY500 MULTICAP 50:25:25 | 0.5% | 4.6% | 8.7% |
You may also like the below Video Courses
FAQ about JB CHEMICALS & PHARMACEUTICALS
Is JB CHEMICALS & PHARMACEUTICALS good for long term investment?
As on Jun 12,2025, the Fundamentals of JB CHEMICALS & PHARMACEUTICALS look Strong and hence it may be good for long term investment! See Financial Performance of JB CHEMICALS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is JB CHEMICALS & PHARMACEUTICALS UnderValued or OverValued?
As on Jun 12,2025, JB CHEMICALS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of JB CHEMICALS & PHARMACEUTICALS ?
As on Jun 12,2025, the Intrinsic Value of JB CHEMICALS & PHARMACEUTICALS is Rs. 609.79 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 616.80
Fair Value [Median EV / Sales Model] : Rs. 590.94
Fair Value [Median Price / Sales Model] : Rs. 609.79
Estimated Median Fair Value of JB CHEMICALS & PHARMACEUTICALS : Rs. 609.79
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.